Categories: News

NYSE Content Advisory: Pre-Market Update + President of South Korea rings Opening Bell

NEW YORK, Sept. 25, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Ashley Mastronardi delivers the pre-market update on September 25th

- Advertisement -
  • Equities are fractionally lower following two straight days of losses across the major averages. Investors will focus on new developments in the AI trade, as well as key economic data out ahead of today’s open.
  • The Labor Department released its latest weekly jobless claims data this morning amid a cooling labor market. Fed Chair Jerome Powell said this week that weakness in the labor market is outweighing concerns about sticky inflation.
  • Today at the New York Stock Exchange, the President of South Korea, Lee Jae Myung, will ring the Opening Bell amid the 80th session of the United Nations General Assembly.  

Opening Bell
H.E. Lee Jae Myung, President of South Korea, rings the Opening Bell

- Advertisement -

Closing Bell
Tetra Technologies (NYSE: TTI) celebrates ONE TETRA – The Path to 2030

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2782150/NYSE_Market_Update_Sept_25.mp4
Logo – https://mma.prnewswire.com/media/2581322/5530553/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–president-of-south-korea-rings-opening-bell-302567144.html

- Advertisement -

Recent Posts

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE…

1 hour ago

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

January 16, 2026 16:05 ET  | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE…

1 hour ago

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Company to host conference call and webcast on Tuesday, January 20, 2026 at 8:00 am…

1 hour ago

NeuroDyne Drops: Sharp Mind, Enhanced Memory, and Lasting Focus As Nature Intended, Ingredients

NEURODYNE DROPS INTRODUCED AS A COGNITIVE WELLNESS SUPPLEMENT SUPPORTING HEALTHY MEMORY, FOCUS, AND MENTAL CLARITY…

10 hours ago

Optivell Officially Announced as a Vision Support Formula for Preventive Eye Wellness

New York City, NY, Jan. 17, 2026 (GLOBE NEWSWIRE) -- OPTIVELL INTRODUCED AS A NEW…

10 hours ago

Sugar Clean Drops: Top Blood Sugar Support Supplement for Metabolic Wellness and Energy Support

SUGAR CLEAN DROPS ANNOUNCED AS A NEW SUPPLEMENT SUPPORTING HEALTHY BLOOD SUGAR AND METABOLIC WELLNESS…

10 hours ago